Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 4
2014 1
2015 2
2016 2
2017 3
2018 3
2019 1
2020 5
2021 4
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Cost-effectiveness of vaccination against herpes zoster.
de Boer PT, Wilschut JC, Postma MJ. de Boer PT, et al. Hum Vaccin Immunother. 2014;10(7):2048-61. doi: 10.4161/hv.28670. Hum Vaccin Immunother. 2014. PMID: 25424815 Free PMC article. Review.
Targeted Screening for Chronic Q Fever, the Netherlands.
Reukers DFM, de Boer PT, Loohuis AO, Wever PC, Bleeker-Rovers CP, van Gageldonk-Lafeber AB, van der Hoek W, Timen A. Reukers DFM, et al. Among authors: de boer pt. Emerg Infect Dis. 2022 Jul;28(7):1403-1409. doi: 10.3201/eid2807.212273. Emerg Infect Dis. 2022. PMID: 35731163 Free PMC article.
Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands.
de Boer PT, de Lange MMA, Wielders CCH, Dijkstra F, van Roeden SE, Bleeker-Rovers CP, Oosterheert JJ, Schneeberger PM, van der Hoek W. de Boer PT, et al. Emerg Infect Dis. 2020 Feb;26(2):238-246. doi: 10.3201/eid2602.181772. Emerg Infect Dis. 2020. PMID: 31961297 Free PMC article.
The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years.
McDonald SA, Lagerweij GR, de Boer P, de Melker HE, Pijnacker R, Mughini Gras L, Kretzschmar ME, den Hartog G, van Gageldonk-Lafeber AB; RIVM COVID-19 surveillance, epidemiology team; van den F S, Wallinga J. McDonald SA, et al. Among authors: de boer p. Eur J Epidemiol. 2022 Oct;37(10):1035-1047. doi: 10.1007/s10654-022-00895-0. Epub 2022 Aug 11. Eur J Epidemiol. 2022. PMID: 35951278 Free PMC article.
Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020.
de Gier B, de Oliveira Bressane Lima P, van Gaalen RD, de Boer PT, Alblas J, Ruijten M, van Gageldonk-Lafeber AB, Waegemaekers T, Schreijer A, van den Hof S, Hahné SJ. de Gier B, et al. Among authors: de boer pt. Euro Surveill. 2020 Dec;25(50):2001884. doi: 10.2807/1560-7917.ES.2020.25.50.2001884. Euro Surveill. 2020. PMID: 33334396 Free PMC article.
29 results